4 557

Cited 4 times in

Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer.

Authors
 Lee, Maria  ;  Paek, Jiheum  ;  Lee, San Hui  ;  Yim, Ga Won  ;  Kim, Sang Wun  ;  Kim, Sunghoon  ;  Kim, Jae Hoon  ;  Kim, Young Tae  ;  Nam, Eun Ji 
Citation
 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, Vol.21(7) : 1306-1311, 2011 
Journal Title
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
ISSN
 1048-891X 
Issue Date
2011
MeSH
Adenocarcinoma/secondary ; Adenocarcinoma/surgery* ; Adult ; Feasibility Studies ; Female ; Humans ; Laparoscopy* ; Middle Aged ; Neoplasm Metastasis ; Ovarian Neoplasms/secondary ; Ovarian Neoplasms/surgery* ; Stomach Neoplasms/pathology ; Treatment Outcome
Keywords
Laparoscopy ; Metastasectomy ; Ovarian metastases ; Gastric cancer
Abstract
OBJECTIVES: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM).

METHODS: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011.

RESULTS: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group.

CONCLUSIONS: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.
Full Text
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00009577-201110000-00022&LSLINK=80&D=ovft
DOI
10.1097/IGC.0b013e31822620e3
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Sang Wun(김상운) ORCID logo https://orcid.org/0000-0002-8342-8701
Kim, Sung Hoon(김성훈) ORCID logo https://orcid.org/0000-0002-1645-7473
Kim, Young Tae(김영태) ORCID logo https://orcid.org/0000-0002-7347-1052
Kim, Jae Hoon(김재훈) ORCID logo https://orcid.org/0000-0001-6599-7065
Nam, Eun Ji(남은지) ORCID logo https://orcid.org/0000-0003-0189-3560
Paek, Ji Heum(백지흠)
Lee, Maria(이마리아)
Lee, San Hui(이산희)
Yim, Ga Won(임가원)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/94555
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links